Interview | Prof. Dr. Petra Ritter, Head of TEF-Health and Dr. Dirk Schlesinger, Head of TÜV AI Lab
“Ultimately, the goal is to bring health-innovations Made in Europe to the marketplace.”
“Ultimately, the goal is to bring health-innovations Made in Europe to the marketplace.”
Diverse challenges and opportunities
Christiane von der Eltz was appointed to the Executive Board of BERLIN-CHEMIE on June 1 of this year and is responsible for the Pharma Germany division. The qualified pharmacist brings with her a wealth of experience in the pharmaceutical industry.…
The start-up Formo is a food biotech company that uses biotechnological processes to develop proteins for the food of the future. We spoke to Sandra Wilde, Formo’s Head of Food Science, about the current development status of the company and their…
Interview with: Prof. Jens Kurreck, TU Berlin and Director of the 3R Center Berlin
Researchers at the Berlin Institute of Health in the Charité (BIH) have teamed up with colleagues from Cellbricks to develop a 3D printer that can produce a biological wound closure. The development is intended to reach high altitudes and help…
ProBioGen was founded in Berlin in 1994, and has been part of the Egyptian Minapharm Group since 2010. The biotech company and its subsidiary MiGenTra operate around the globe and have years of experience developing and producing biopharmaceuticals…
GrownValve is a spin-off of the Deutsches Herzzentrum Berlin and Charité. The company was founded in 2019. It develops patient-specific, endogenous heart valves, with a focus on pediatrics. We interview Jasper Emeis, research associate of GrOwnValve…
Björn von Siemens is co-founder and managing director of caresyntax GmbH. The company develops algorithms that analyze risk factors during surgery and provide decision support. The company, based in Berlin and Boston, recently raised 100 million US…